Mastering Diabetes Study

Sponsor
Ohio University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04454957
Collaborator
Memorial Health System (Other)
100
1
2
238.2
0.4

Study Details

Study Description

Brief Summary

This is a program evaluation that will evaluate the effectiveness of Mastering Diabetes, a therapeutic lifestyle change (TLC) program to control prediabetes and type 2 diabetes.

Lifestyle change, focused on dietary change, physical activity, stress management and control of unhealthy substances has been demonstrated effective in preventing the progression of prediabetes, as well as reversal of diabetes and type 2 diabetes mellitus (T2DM).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mastering Diabetes
N/A

Detailed Description

This will be a nonrandomized controlled study. Participants will self select to be a part of this intervention. The control data will be aggregated matched data from participants in the corporate wellness program at Memorial Health System, who choose not to participate in the intervention.

Study participants will have met the inclusion criteria. Potential participants will be provided with a short summary of this program as a potential activity for their participation, with a link leading to a landing page, which will explain the study in more detail, and will include a link to the consent.

If the potential participant is interested, they can click the link to move to the on line consent. If they agree to the consent, they will be taken to an on line HIPAA release form, which will also need an electronic agreement to be enrolled into the study signified by typing in the participant's name and date of birth.

Once this is completed, an email with an enrollment code and link to Mastering Diabetes will be sent the participant.

Mastering Diabetes Program Description:

The Mastering Diabetes Program is based on the Mastering Diabetes Method, which is based on almost 100 years of evidence based research demonstrating the effectiveness of a low-fat, plant-based, whole-food diet to reverse insulin resistance. Members are provided with a step-by-step online course that educates them how to transition to a low-fat, plant-based, whole-food lifestyle and reduce the overwhelm associated with ineffective pharmaceutical medication and ineffective dietary advice.

The online course provides members with detailed information about the root cause of insulin resistance, the effect of a high-fat diet on increasing insulin resistance, how to achieve excellent blood glucose values in the short-term and in the long-term, what laboratory tests to get to measure progress, an overview of oral diabetes medication and insulin, how to track hour-by-hour decisions for excellent blood glucose control, how to lose weight permanently using a low-fat, plant-based, whole-food diet, how to buy food, where to buy food, how to prepare food easily, the benefits of intermittent fasting for improved insulin sensitivity, how to perform an intermittent fast for excellent results, how to adopt an exercise regimen, how to control your blood glucose before, during, and after exercise, how to change your breakfast, lunch, dinner, and also provides members with a collection of delicious and simple recipes.

The program also provides members with direct access to expert coaches via an online community containing thousands of others living with all forms of diabetes, including type 1 diabetes, type 1.5 diabetes, prediabetes, type 2 diabetes, and gestational diabetes. In addition, members get access to live biweekly Q&A videoconferences in which they can interact with coaches and personalize their experience. The cost of full coaching program is $399 for the first 3 months, then $99 per month thereafter.

Participants, having enrolled in the wellness program, will already, as a part of that study, have agreed to have data collected at baseline and yearly thereafter, including BMI, blood pressure, resting pulse, lipid panel, hemoglobin A1c, health risk assessment survey, absenteeism and health claims data at baseline and yearly thereafter. If not collected within 60 days, a new set of data will be collected to serve as baseline for this study. This is not specific for this study, but is the case for any new program activity that a participant in the corporate wellness study begins.

Specifically for this study the health risk assessment data collection (including lab analysis) will also be repeated at 12 weeks. The lab work is accomplished at any MHS lab facility, according to current medical system standards.

Participant health claims data will also be evaluated, beginning with the prior year's data, if available from MHS Human Resources, being utilized as a baseline, and followed for the subsequent years of the study.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
Nonrandomized controlled interventional studyNonrandomized controlled interventional study
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effectiveness of a Virtual Therapeutic Lifestyle Change Program for Diabetes and Prediabetes
Actual Study Start Date :
Aug 24, 2020
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Jun 30, 2040

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mastering Diabetes

Adults (hospital employees, their spouses, and community members) who have been identified as having diabetes or prediabetes based on a health risk assessment, who have chosen to participate in Mastering Diabetes. They may or may not be receiving additional usual care.

Behavioral: Mastering Diabetes
Virtual (on-line) lifestyle change program, focused on a plant-based, whole food diet and physical activity.

No Intervention: Usual care

Employees and spouses of the hospital system who are participating in the employee wellness program, who have been identified as having diabetes or prediabetes based on a health risk assessment, who have chosen not to participate in Mastering Diabetes. They may or may not be receiving additional usual care.

Outcome Measures

Primary Outcome Measures

  1. HbA1c [up to 20 years]

    glycosylated hemoglobin measured from venous blood

  2. BMI [up to 20 years]

    Body mass index calculated from height and weight

  3. Healthcare expenditures [up to 20 years]

    Monetary amount spent for healthcare

Secondary Outcome Measures

  1. Total cholesterol [baseline, 12 weeks, 1 yearly, then yearly for up to 20 years]

    Measured from a lipid panel done on venous blood

  2. Low density lipoprotein cholesterol [baseline, 12 weeks, 1 yearly, then yearly for up to 20 years]

    Calculated from a lipid panel done on venous blood

  3. High density lipoprotein cholesterol [baseline, 12 weeks, 1 yearly, then yearly for up to 20 years]

    Measured from a lipid panel done on venous blood

  4. Triglyceride [baseline, 12 weeks, 1 yearly, then yearly for up to 20 years]

    Measured from a lipid panel done on venous blood

  5. Exercise level [baseline, 12 weeks, 1 yearly, then yearly for up to 20 years]

    Amount of time spent per week in moderate to vigorous physical activity

  6. Dietary Recall [baseline, 12 weeks, 1 yearly, then yearly for up to 20 years]

    Daily or weekly average of foods consumed during the last 7 days

  7. Patient Health Questionnaire [baseline, 12 weeks, 1 yearly, then yearly for up to 20 years]

    mood screening questions; two for anxiety

  8. Patient Health Questionnaire [baseline, 12 weeks, 1 yearly, then yearly for up to 20 years]

    mood screening questions; two for depression.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18-75 years at enrollment

  • Has a diagnosis of diabetes or prediabetes or a HbA1c of 5.7 or higher.

  • Are able to participate in physical activity.

  • Are willing to use a smartphone or computer to access the online education modules and online community, and have reliable daily Internet access with a device with a webcam

  • Have an email account and an Internet connection at home

  • Are able to purchase and transport fresh produce from a local grocery store to their house on a weekly basis

  • Are able to prepare food in their house or get help preparing food in their house following recipes and meal examples provided in the online course

  • Are open-minded about eating a plant-based diet, performing periodic intermittent fasting (16-24 hours, once a week),

  • Are willing to increase movement of their body 5-6 days per week

  • Are willing to participate in an online community for support and coaching

  • Are willing to participate in biweekly videoconferencing for support and coaching

  • Are willing to be courteous and respectful to others in the online community

Exclusion Criteria:
  • Has been told by a medical provider to not participate in physical activity.

  • Has a medical condition that prevents walking at least a mile a day.

  • Deemed unsuitable to exercise by Dr. Drozek or other members of the wellness team.

  • Has a diagnosis of dementia.

  • Is pregnant or planning to become pregnant during the program

  • Does not speak or understand English

  • Advanced renal disease (stage 4 or 5) with or without hemodialysis

  • Congestive heart failure

  • Has inflammatory bowel disease (Crohns disease, ulcerative colitis)

  • Is fed by a feeding tube

  • Is taking Coumadin or warfarin

  • Inability to use email, a smartphone, or the Internet

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ohio University Athens Ohio United States 45701

Sponsors and Collaborators

  • Ohio University
  • Memorial Health System

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
David Drozek, Associate Professor, Ohio University
ClinicalTrials.gov Identifier:
NCT04454957
Other Study ID Numbers:
  • 20-X-96
First Posted:
Jul 2, 2020
Last Update Posted:
Mar 25, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by David Drozek, Associate Professor, Ohio University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 25, 2022